Join us for our General Meetings Tuesday Nights at 7pm in Anspach 151. This semester's dates: Jan 29, Feb 12 & 26, March 12 & 26, April 9 & 23. Come join our dynamic network of students from all over campus, dedicated to a single cause.
Wednesday, November 2, 2011
Anti-malarial compound from UC Berkeley
UC Berkeley originally licensed the anti-malarial compound artemisinin to Amyris and the Intitute for One World Health (iOWH), with global access provisions in 2004, after receiving a grant from the Gates foundation. Now, they are planning on producing the drug for combination therapy with the help of sanofi in 2012. This semisynthetic compound should lower the price significantly and stabilize the availability of the drug which is originally derived from a plant grown in China and Vietnam.
Original Source here
For more info:
iOWH press release: Here
Artemisinin Case Study (Berkeley TTO): Here
A great example of the importance of global access licensing!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Please give us input on our fight 4 equal access.